论文信息 - Antitumor effects of dabrafenib, trametinib, and panitumumab as single agents and in combination in BRAF-mutant colorectal carcinoma (CRC) models. - 字舞流文

Antitumor effects of dabrafenib, trametinib, and panitumumab as single agents and in combination in BRAF-mutant colorectal carcinoma (CRC) models.

K. Bachman | M. Motwani | J. Zou | A. Hoos | K. Orford | Junping Jing | Maureen R. Bleam | Li Liu | Hong Shi | V. Zhang